10 completed, 3 not yet recruiting, 3 recruiting, 1 active not recruiting. 8 Not applicable, 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 3, Recruiting 3, Not yet recruiting 2 |
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Coeliac Disease: new trials by email Literature Review of Coeliac Disease trials Research Report on Coeliac Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation of the CDAT in the Polish Paediatric Population CDAT - phase 1, CDAT - phase 2 - Coeliac Disease, Celiac Disease in Children | Not yet recruiting | Medical University of Warsaw | 20 | 2026-09-01 | 2025-09-03 | |
| Interest of Urinary Measurement of Immunogenic Gluten Peptides (GIP) in the Follow-up of Pediatric Celiac Patients. Urinary measurement of GIP, Usual follow-up and measurement of urinary GIP. - Coeliac Disease | Not applicable | Not yet recruiting | Fondation Lenval | 100 | 2026-06-01 | 2026-05-11 |
| Efficacy of Symprove Probiotics in Coeliac Disease Symprove Probiotic - Coeliac Disease, Probiotic | Not applicable | Recruiting | Sheffield Teaching Hospitals NHS Foundation Trust | 24 | 2026-01-29 | 2026-03-17 |
| Virtual Dietetic Interventions in Patients With Coeliac Virtual Dietetic First-Appointment Webinar for Coeliac Disease, Standard Dietetic Consultation (Face-to-Face or Telephone) - Coeliac Disease | Not applicable | Recruiting | Sheffield Teaching Hospitals NHS Foundation Trust | 60 | 2025-12-01 | 2026-03-18 |
| Supporting Children and Young People to Live Well With Coeliac Disease: A RCT Parent self-help psychological resource - Coeliac Disease, Celiac Disease in Children | Not applicable | Not yet recruiting | University of Surrey | 350 | 2025-05-01 | 2025-04-16 |
| A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease Amlitelimab, Placebo, SIGE - Coeliac Disease, Celiac Disease | Phase 2 | Active not recruiting | Sanofi | 229 | 2024-08-29 | 2026-08-31 |
| A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease KAN-101, Placebo - Celiac Disease, Coeliac Disease | Phase 2 | Completed | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 55 | 2023-12-13 | 2025-12-18 |
| Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies Dietary intervention, Standard of care, Cardiovascular risk-related parameters - Coeliac Disease | Not applicable | Recruiting | University of Pecs | 190 | 2022-09-01 | 2025-01-22 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole GSK3915393 Capsules, GSK3915393 Solution for Infusion, Placebo capsules - Celiac Disease, Coeliac Disease | Phase 1 | Completed | GlaxoSmithKline | 65 | 2020-11-04 | 2023-05-09 |
| Rapid Technique for the Detection of Intestinal Anti-transglutaminase Antibodies Coeliac Disease | Unknown | IRCCS Burlo Garofolo | 163 | 2020-02-15 | 2023-03-27 | |
| Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease Coeliac Disease | Completed | Hospital Mutua de Terrassa | 765 | 2020-01-01 | 2026-01-23 | |
| Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease Nexvax2, Placebo - Celiac Disease, Intestinal Disease | Phase 1 | Completed | ImmusanT, Inc. | 14 | 2018-05-01 | 2018-09-20 |
| Low FODMAPs Diet in Gastrointestinal Disorders low FODMAPs diet - Inflammatory Bowel Diseases, Irritable Bowel Syndrome | Not applicable | Completed | Federico II University | 150 | 2016-07-01 | 2018-08-23 |
| Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting Simtomax - Coeliac Disease | Not applicable | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 502 | 2016-07-01 | 2017-11-24 |
| MAgnetic Resonance Imaging in COeliac Disease Gluten free diet - Celiac Disease, Coeliac Disease | Completed | University of Nottingham | 72 | 2016-01-01 | 2020-04-21 | |
| European Novel Motorized Spiral Endoscopy Trial motorized spiral enteroscopy - Disorder of Small Intestine, Gastrointestinal Hemorrhage | Not applicable | Completed | Evangelisches Krankenhaus Düsseldorf | 136 | 2015-11-01 | 2018-02-14 |
| A Blood Based Diagnostic Test for Coeliac Disease Coeliac Disease, Non Coeliac Gluten Sensitivity | Completed | Oslo University Hospital | 144 | 2015-02-01 | 2025-07-30 | |
| Safety Study of Nexvax2 in Subjects With Coeliac Disease 9 micrograms Nexvax2, 30 micrograms Nexvax2, 90 micrograms Nexvax2 - Coeliac Disease, Celiac Disease | Phase 1 | Completed | Nexpep Pty Ltd | 34 | 2009-04-01 | 2011-04-07 |
Celiac Disease (18) · Anemia, Iron-Deficiency (1) · Crohn Disease (1) · Digestive System Diseases (1) · Disease (1) · Enteropathy-Associated T-Cell Lymphoma (1) · Gastrointestinal Diseases (1) · Gastrointestinal Hemorrhage (1) · Inflammatory Bowel Diseases (1) · Intestinal Diseases (1) · Irritable Bowel Syndrome (1) · Malabsorption Syndromes (1) · Metabolic Diseases (1)
Nutritional and Metabolic Diseases (18) · Digestive System Diseases (17) · Gastrointestinal Diseases (17) · Intestinal Diseases (17) · Malabsorption Syndromes (17) · Metabolic Diseases (17) · Gastroenteritis (2) · Hemic and Lymphatic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Anemia (1) · Anemia, Hypochromic (1) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Hematologic Diseases (1)
Diet Therapy (1) · Diet, Gluten-Free (1) · FODMAP Diet (1) · Itraconazole (1) · Nexvax2 (1) · Standard of Care (1) · Water (1)
Sheffield Teaching Hospitals NHS Foundation Trust (3) · Evangelisches Krankenhaus Düsseldorf (1) · Federico II University (1) · Fondation Lenval (1) · GlaxoSmithKline (1) · Hospital Mutua de Terrassa (1) · IRCCS Burlo Garofolo (1) · ImmusanT, Inc. (1) · Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA (1) · Medical University of Warsaw (1) · Nexpep Pty Ltd (1) · Oslo University Hospital (1) · Sanofi (1) · University of Nottingham (1) · University of Pecs (1)
United Kingdom (7) · Australia (3) · Germany (3) · Italy (3) · Belgium (2) · Canada (2) · Finland (2) · France (2) · Israel (2) · Netherlands (2) · Poland (2) · Spain (2) · United States (2) · Argentina (1) · Brazil (1)
David S Sanders, MBChB, MD (1) · David Sanders (1) · Fabiana Castiglione (1) · Gregor Brown, MBBS PhD FRACP (1) · Horst Neuhaus, MD (1) · James Daveson, MBBS FRACP (1) · Judit Bajor, MD, PhD (1) · Knut EA Ludin, PhD, MD (1) · Luca Marciani, PhD (1) · Robert Anderson, PhD, FRACP (1)
PMID 20650871, PMID 29146521, PMID 32332141, PMID 37709338, PMID 39384235, PMID 39662692